The Receptor-Binding Site of the Measles Virus Hemagglutinin Protein Itself Constitutes a Conserved Neutralizing Epitope
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in | Journal of Virology Vol. 87; no. 6; pp. 3583 - 3586 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.03.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing epitope (CNE). Several receptor-interacting residues constitute the CNE. Thus, viral escape from neutralization has to be associated with loss of receptor-binding activity. Since interactions with both the signaling lymphocyte activation molecule (SLAM) and nectin4 are critical for MV pathogenesis, its escape, which results from loss of receptor-binding activity, should not occur in nature. Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing epitope (CNE). Several receptor-interacting residues constitute the CNE. Thus, viral escape from neutralization has to be associated with loss of receptor-binding activity. Since interactions with both the signaling lymphocyte activation molecule (SLAM) and nectin4 are critical for MV pathogenesis, its escape, which results from loss of receptor-binding activity, should not occur in nature.Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing epitope (CNE). Several receptor-interacting residues constitute the CNE. Thus, viral escape from neutralization has to be associated with loss of receptor-binding activity. Since interactions with both the signaling lymphocyte activation molecule (SLAM) and nectin4 are critical for MV pathogenesis, its escape, which results from loss of receptor-binding activity, should not occur in nature. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI |
Author | Richard K. Plemper Kouji Sakai Makoto Takeda Hideo Fukuhara Melinda A. Brindley Yuri Ito Maino Tahara Shinji Ohno Paul A. Rota Katsuhiro Komase Katsumi Maenaka |
Author_xml | – sequence: 1 givenname: Maino surname: Tahara fullname: Tahara, Maino organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 2 givenname: Shinji surname: Ohno fullname: Ohno, Shinji organization: Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan – sequence: 3 givenname: Kouji surname: Sakai fullname: Sakai, Kouji organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 4 givenname: Yuri surname: Ito fullname: Ito, Yuri organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan – sequence: 5 givenname: Hideo surname: Fukuhara fullname: Fukuhara, Hideo organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan – sequence: 6 givenname: Katsuhiro surname: Komase fullname: Komase, Katsuhiro organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 7 givenname: Melinda A. surname: Brindley fullname: Brindley, Melinda A. organization: Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA – sequence: 8 givenname: Paul A. surname: Rota fullname: Rota, Paul A. organization: Measles, Mumps, Rubella and Herpesviruses Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 9 givenname: Richard K. surname: Plemper fullname: Plemper, Richard K. organization: Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA – sequence: 10 givenname: Katsumi surname: Maenaka fullname: Maenaka, Katsumi organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan – sequence: 11 givenname: Makoto surname: Takeda fullname: Takeda, Makoto organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23283964$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1v1DAQxS3Uim4LN84o3DiQ4o_Eji9IZdXSReVDUCpuljeZZF0ldrCdLe1fX2-3RYCExGk0mt88Pb23j3ass4DQM4IPCaHV6_cXi0PMMJU5oY_QjGBZ5WVJih00w5jSvGTV9z20H8IlxqQoePEY7VFGKyZ5MUM_z1eQfYEaxuh8_tbYxtgu-2oiZK7NYjp-AB16CNmF8VPITmHQXddP0Vhjs8_eRUhzEQP0bTZ3NkQTp5hwfbeBX0OTfYQpet2bm4328WiiG-EJ2m11H-Dp_TxA306Oz-en-dmnd4v50Vlel1jGXJaypctlAwXDLaesEUJQWmBOuOZQSlEyzdqi0SAIl5IJoJxIyQVLEeBaswP0Zqs7TssBmhrsxooavRm0v1ZOG_XnxZqV6txasVJSQkUSeHkv4N2PCUJUgwk19L224KagCKOsIlzg4j9QQjmnsmIJff67rV9-HppJAN0CtXcheGhVbaKOxm1cml4RrDb1q1S_uqtfEZqeXv319KD7D_zFFl-ZbnVlPCgdBnW5NqoSiqcEktFbAU-8ZQ |
CitedBy_id | crossref_primary_10_1016_j_virusres_2017_04_018 crossref_primary_10_1371_journal_pone_0073374 crossref_primary_10_1128_JVI_01248_18 crossref_primary_10_1016_j_vaccine_2016_10_010 crossref_primary_10_2217_fvl_2017_0071 crossref_primary_10_3390_v8040109 crossref_primary_10_1016_j_coviro_2020_04_002 crossref_primary_10_1016_j_virol_2015_03_035 crossref_primary_10_1038_nrdp_2016_49 crossref_primary_10_3390_ijms21124435 crossref_primary_10_1016_j_virol_2014_01_027 crossref_primary_10_1016_j_ijmm_2024_151607 crossref_primary_10_3389_fmolb_2023_1302737 crossref_primary_10_3390_v9010011 crossref_primary_10_1016_j_vaccine_2015_12_006 crossref_primary_10_1093_infdis_jiv434 crossref_primary_10_2222_jsv_67_3 crossref_primary_10_1016_j_xcrm_2021_100225 crossref_primary_10_1111_febs_14991 crossref_primary_10_1128_JVI_02166_17 crossref_primary_10_3390_medicina58050680 crossref_primary_10_3390_v8080216 crossref_primary_10_1093_infdis_jiw480 crossref_primary_10_1007_s00430_016_0451_4 crossref_primary_10_1128_jvi_00758_24 crossref_primary_10_1186_s13063_022_06493_5 crossref_primary_10_1016_S0140_6736_17_31463_0 crossref_primary_10_2147_IJN_S386560 crossref_primary_10_1038_srep11648 crossref_primary_10_3390_v11111017 |
Cites_doi | 10.1099/0022-1317-66-7-1397 10.1007/s00705-003-0159-9 10.1128/jvi.69.3.1913-1916.1995 10.1128/JVI.02691-07 10.1016/S0140-6736(03)12661-X 10.1038/nsmb.1969 10.1128/JVI.79.17.11547-11551.2005 10.1038/nature10639 10.1038/nsmb.2432 10.1128/JVI.78.1.302-313.2004 10.1371/journal.ppat.1002240 10.1128/JVI.00867-08 10.1099/vir.0.014944-0 10.1093/infdis/jir133 10.1128/JVI.74.14.6643-6647.2000 10.1074/jbc.M110.102590 10.3389/fmicb.2011.00279 10.1016/j.vaccine.2009.04.010 10.1016/0042-6822(86)90371-5 10.1128/JVI.02033-12 10.1038/35022579 10.1089/088282402760312331 10.1073/pnas.0707830104 10.1006/viro.1993.1042 10.1016/j.virusres.2011.09.023 |
ContentType | Journal Article |
Copyright | Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 7U9 H94 5PM |
DOI | 10.1128/JVI.03029-12 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 3586 |
ExternalDocumentID | PMC3592127 23283964 10_1128_JVI_03029_12 jvi_87_6_3583 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI083402 |
GroupedDBID | --- -~X 0R~ 18M 29L 2WC 39C 4.4 53G 5GY 5RE 5VS 85S AAFWJ AAGFI AAYXX ABPPZ ACGFO ACNCT ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 N9A O9- OK1 P2P RHI RNS RPM RSF TR2 UPT W2D W8F WH7 WOQ YQT ~02 ~KM .55 .GJ 3O- 41~ 6TJ AAYJJ ADXHL AFFNX AI. C1A CGR CUY CVF D0S ECM EIF MVM NPM OHT VH1 X7M Y6R ZGI ZXP 7X8 7T5 7U9 H94 5PM |
ID | FETCH-LOGICAL-c509t-959f2bbde430f623d7772240616a6e59753a3f4dae7169937e261996735140ca3 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 18:34:00 EDT 2025 Fri Jul 11 01:36:32 EDT 2025 Fri Jul 11 07:25:38 EDT 2025 Mon Jul 21 06:06:03 EDT 2025 Thu Apr 24 23:10:02 EDT 2025 Tue Jul 01 01:02:21 EDT 2025 Wed May 18 15:26:13 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c509t-959f2bbde430f623d7772240616a6e59753a3f4dae7169937e261996735140ca3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://jvi.asm.org/content/jvi/87/6/3583.full.pdf |
PMID | 23283964 |
PQID | 1312662983 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | pubmed_primary_23283964 proquest_miscellaneous_1323816704 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3592127 crossref_citationtrail_10_1128_JVI_03029_12 highwire_asm_jvi_87_6_3583 proquest_miscellaneous_1312662983 crossref_primary_10_1128_JVI_03029_12 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-03-01 |
PublicationDateYYYYMMDD | 2013-03-01 |
PublicationDate_xml | – month: 03 year: 2013 text: 2013-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2013 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_10_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 Leonard VH (e_1_3_2_17_2) 2008; 118 2424173 - Virology. 1986 Jul 15;152(1):58-65 14579178 - Arch Virol. 2003 Nov;148(11):2195-206 21901103 - PLoS Pathog. 2011 Aug;7(8):e1002240 18003910 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40 14671112 - J Virol. 2004 Jan;78(1):302-13 23202587 - Nat Struct Mol Biol. 2013 Jan;20(1):67-72 10864679 - J Virol. 2000 Jul;74(14):6643-7 12620751 - Lancet. 2003 Mar 1;361(9359):763-73 2410551 - J Gen Virol. 1985 Jul;66 ( Pt 7):1397-409 19490984 - Vaccine. 2009 Jun 12;27(29):3838-48 23115278 - J Virol. 2013 Jan;87(1):666-75 18799577 - J Virol. 2008 Dec;82(23):11979-84 21963661 - Virus Res. 2011 Dec;162(1-2):72-9 10972291 - Nature. 2000 Aug 24;406(6798):893-7 21666216 - J Infect Dis. 2011 Jul;204 Suppl 1:S71-7 19710253 - J Gen Virol. 2009 Dec;90(Pt 12):2982-9 12479395 - Viral Immunol. 2002;15(3):451-71 7685966 - Virology. 1993 Jan;192(1):351-4 18568079 - J Clin Invest. 2008 Jul;118(7):2448-58 18287234 - J Virol. 2008 May;82(9):4630-7 22347873 - Front Microbiol. 2012 Jan 13;2:279 20435897 - J Biol Chem. 2010 Jul 2;285(27):20882-90 22048310 - Nature. 2011 Dec 22;480(7378):530-3 16103210 - J Virol. 2005 Sep;79(17):11547-51 21217702 - Nat Struct Mol Biol. 2011 Feb;18(2):135-41 7853533 - J Virol. 1995 Mar;69(3):1913-6 |
References_xml | – ident: e_1_3_2_14_2 doi: 10.1099/0022-1317-66-7-1397 – ident: e_1_3_2_27_2 doi: 10.1007/s00705-003-0159-9 – ident: e_1_3_2_24_2 doi: 10.1128/jvi.69.3.1913-1916.1995 – ident: e_1_3_2_16_2 doi: 10.1128/JVI.02691-07 – ident: e_1_3_2_9_2 doi: 10.1016/S0140-6736(03)12661-X – ident: e_1_3_2_20_2 doi: 10.1038/nsmb.1969 – ident: e_1_3_2_6_2 doi: 10.1128/JVI.79.17.11547-11551.2005 – ident: e_1_3_2_4_2 doi: 10.1038/nature10639 – ident: e_1_3_2_19_2 doi: 10.1038/nsmb.2432 – ident: e_1_3_2_18_2 doi: 10.1128/JVI.78.1.302-313.2004 – ident: e_1_3_2_3_2 doi: 10.1371/journal.ppat.1002240 – ident: e_1_3_2_22_2 doi: 10.1128/JVI.00867-08 – ident: e_1_3_2_8_2 doi: 10.1099/vir.0.014944-0 – ident: e_1_3_2_10_2 doi: 10.1093/infdis/jir133 – ident: e_1_3_2_15_2 doi: 10.1128/JVI.74.14.6643-6647.2000 – ident: e_1_3_2_21_2 doi: 10.1074/jbc.M110.102590 – ident: e_1_3_2_5_2 doi: 10.3389/fmicb.2011.00279 – ident: e_1_3_2_25_2 doi: 10.1016/j.vaccine.2009.04.010 – ident: e_1_3_2_26_2 doi: 10.1016/0042-6822(86)90371-5 – volume: 118 start-page: 2448 year: 2008 ident: e_1_3_2_17_2 article-title: Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed publication-title: J. Clin. Invest. – ident: e_1_3_2_13_2 doi: 10.1128/JVI.02033-12 – ident: e_1_3_2_2_2 doi: 10.1038/35022579 – ident: e_1_3_2_7_2 doi: 10.1089/088282402760312331 – ident: e_1_3_2_12_2 doi: 10.1073/pnas.0707830104 – ident: e_1_3_2_23_2 doi: 10.1006/viro.1993.1042 – ident: e_1_3_2_11_2 doi: 10.1016/j.virusres.2011.09.023 – reference: 12479395 - Viral Immunol. 2002;15(3):451-71 – reference: 10972291 - Nature. 2000 Aug 24;406(6798):893-7 – reference: 21963661 - Virus Res. 2011 Dec;162(1-2):72-9 – reference: 18287234 - J Virol. 2008 May;82(9):4630-7 – reference: 16103210 - J Virol. 2005 Sep;79(17):11547-51 – reference: 21901103 - PLoS Pathog. 2011 Aug;7(8):e1002240 – reference: 21666216 - J Infect Dis. 2011 Jul;204 Suppl 1:S71-7 – reference: 19710253 - J Gen Virol. 2009 Dec;90(Pt 12):2982-9 – reference: 2410551 - J Gen Virol. 1985 Jul;66 ( Pt 7):1397-409 – reference: 20435897 - J Biol Chem. 2010 Jul 2;285(27):20882-90 – reference: 18003910 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40 – reference: 12620751 - Lancet. 2003 Mar 1;361(9359):763-73 – reference: 22347873 - Front Microbiol. 2012 Jan 13;2:279 – reference: 18799577 - J Virol. 2008 Dec;82(23):11979-84 – reference: 7853533 - J Virol. 1995 Mar;69(3):1913-6 – reference: 14671112 - J Virol. 2004 Jan;78(1):302-13 – reference: 10864679 - J Virol. 2000 Jul;74(14):6643-7 – reference: 19490984 - Vaccine. 2009 Jun 12;27(29):3838-48 – reference: 18568079 - J Clin Invest. 2008 Jul;118(7):2448-58 – reference: 14579178 - Arch Virol. 2003 Nov;148(11):2195-206 – reference: 23115278 - J Virol. 2013 Jan;87(1):666-75 – reference: 21217702 - Nat Struct Mol Biol. 2011 Feb;18(2):135-41 – reference: 7685966 - Virology. 1993 Jan;192(1):351-4 – reference: 2424173 - Virology. 1986 Jul 15;152(1):58-65 – reference: 23202587 - Nat Struct Mol Biol. 2013 Jan;20(1):67-72 – reference: 22048310 - Nature. 2011 Dec 22;480(7378):530-3 |
SSID | ssj0014464 |
Score | 2.2560916 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing... |
SourceID | pubmedcentral proquest pubmed crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3583 |
SubjectTerms | Antibodies, Neutralizing - immunology Antibodies, Viral - immunology Epitopes, B-Lymphocyte - immunology Hemagglutinins, Viral - immunology Measles virus Measles virus - immunology Virus-Cell Interactions |
Title | The Receptor-Binding Site of the Measles Virus Hemagglutinin Protein Itself Constitutes a Conserved Neutralizing Epitope |
URI | http://jvi.asm.org/content/87/6/3583.abstract https://www.ncbi.nlm.nih.gov/pubmed/23283964 https://www.proquest.com/docview/1312662983 https://www.proquest.com/docview/1323816704 https://pubmed.ncbi.nlm.nih.gov/PMC3592127 |
Volume | 87 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCIkXND7XDZCR4KnKyIfjJI-AOq1jG0hrp_JkuY2zZnRp1TQI9tdzZ-ero6DBS9oklmPlfjnfnf27I-QNt1UUcgyBhWNusThkFi7fWRM_CSOYDhLPQYLzySk_HLKjkT9qYrqaXbIa70-uN_JK_keqcA3kiizZf5Bs3SlcgP8gXziChOF4axmD3acW4DhbH1JDUDlLm5X_EyXzmcq75-myyGGKuZIXFzggzKj6BTM0wG9_latZoit3mm0DeVfqM9wLGYMWLHQw5Br77i1AASzWdw81Fi1S5tpB-oHEbNCGEZRm8zqeO9Xlvrtn0zS7TOsQj_xWVsaeF83Vvq7y1P1aLNN2fAJrRVQbtFp8AVCrIzPjGDWLWUzRVmvr4XLiTX9Tqp5vat2UEzSc8s3K30VCw9F5fx80l4tVHppJrlrYP_0sDobHx2LQGw3uknsuOBfaEe9_qteewEFmVY55HHdFl3DDd-2-1w2ZKrn0Jkfl5n7blgEz2CYPSznR9wZGj8gdlT0m900t0p9PyA8AE70JJopgovOEAphoCSaqwUTXwERLMFEDJtoCE5W0BhNtg4mWYHpKhge9wcdDqyzLAR-wHa2syI8SdzyOFfPsBKznOICXqA1DLrnykaktvYTFUmEmJjB_FXrpEQ-QNGJPpPeMbGXzTO0QyrC1r1joSJ-5gS-ZVAnzlB0zyZ3E6ZBu9Y7FpMxZj6VTZkL7rm4oQCJCS0Q4boe8rVsvTK6WP7TbrcQlZH4lLr-nIgwEFwi0DnldCVCApsXlM5mpeZELx3PAmnWjv7dBE5gHNuuQ50bo9VDAdwFvhMOdYA0OdQPM9L5-J0unOuO750dYiWH3Fs_dIw-ar_AF2VotC_US7ObV-JWG-S8ZXcU9 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Receptor-Binding+Site+of+the+Measles+Virus+Hemagglutinin+Protein+Itself+Constitutes+a+Conserved+Neutralizing+Epitope&rft.jtitle=Journal+of+virology&rft.au=Tahara%2C+Maino&rft.au=Ohno%2C+Shinji&rft.au=Sakai%2C+Kouji&rft.au=Ito%2C+Yuri&rft.date=2013-03-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=87&rft.issue=6&rft.spage=3583&rft.epage=3586&rft_id=info:doi/10.1128%2FJVI.03029-12&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |